Evidence is mounting that clinicians can treat serious genetic disorders prenatally by injecting medicine into the amniotic fluid, thus preventing damage that begins in utero.

Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million.

This test provides results as “high risk” or “low risk,” not diagnostic confirmations—but it’s a game-changer in identifying who truly needs further testing. With its superior ...

Although most cases of hypoparathyroidism (hypoPT) are secondary to surgery, a significant proportion (20% to 25%) are due to other etiologies, including autoimmune and genetic causes. Autoimmune ...

Prevent Blindness has declared May the second annual inherited retinal disease and genetic testing month, offering free resources on education and other awareness efforts. Offering a variety of free ...

The following is a summary of “Uptake and patient-related outcomes of mainstreaming genetic testing – a systematic review and meta-analysis,” published in the April 2025 issue of American Journal of ...

By increasing the availability of MSK-ACCESS® powered with SOPHiA DDM™, SOPHiA GENETICS and AstraZeneca aim to understand further how liquid biopsy testing can complement solid tissue testing ...

Back in the United States, Raskind is also advocating for genetic testing in videos posted to his 1.2 million Instagram followers – in between his usual content on life and fatherhood.

Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, and many other specialized testing options. Located in Houston’s Texas Medical Center ...